IHS Chemical Week

Chemical Week Magazine :: Business & Finance :: Europe/Mideast

DSM Sets Ambitious Targets, Divests Citric Acid Business

8:42 AM MDT | October 4, 2010 | Natasha Alperowicz

DSM (Heerlen, the Netherlands) has updated financial targets to include sharply higher Ebitda and higher return on capital. The company also announced the sale of its citric acid business to Adcuram (Munich) and the formation of a joint venture with DuPont in surgical biomedical materials. DSM also plans to expand its biopharmaceutical joint venture with Crucell and is seeking partnerships for its anti-infectives business with companies in China and India. The company has set an Ebitda target of €1.4 billion-€1.6 billion ($1.9 billion-$2.1 billion) and return...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa